This is a combined synopsis/solicitation for commercial services prepared in accordance with the Federal Acquisition Regulation (FAR) format in 15.204-1, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. This solicitation authorized under FAR Part 12 “Acquisition of Commercial Products and Commercial Services” and 13.5 “Simplified Procedures for Certain Commercial Products and Commercial Services” is for the award of one (1) Indefinity Delivery Indefinite Quantity (IDIQ) contract.
The solicitation number is FDA-75F40124Q00047. This solicitation is issued as a Request for Quote (RFQ). This is a Full and Open Competition.
The solicitation document and incorporated provisions and clauses in effect through the Federal Acquisition Circular 2024-04, effective 01 May 2024. FAR and HHSAR provisions and clauses referenced in this RFQ can be found on the following website: https://www.acquisition.gov/browse/index/far
